Intersect ENT
-
Medtronic in agreement with Intersect ENT
Acquisition to add innovative bioabsorbable drug release platform to chronic rhinosinusitis portfolio Medtronic has entered into a definitive agreement with…
Read More »
Acquisition to add innovative bioabsorbable drug release platform to chronic rhinosinusitis portfolio Medtronic has entered into a definitive agreement with…
Read More »